These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 5071006
1. [Excitability of the spinal motor neurons in patients with Parkinsonism and athetosis treated with L-dopa]. Messina C. Riv Neurol; 1972; 42(3):225-31. PubMed ID: 5071006 [No Abstract] [Full Text] [Related]
2. [Study of H and T reflexes in Parkinsonism. Modification of these reflexes by L-Dopa]. Krassoievitch M, Tissot R. Encephale; 1971; 60(1):36-57. PubMed ID: 4253001 [No Abstract] [Full Text] [Related]
4. [2-year experiences with a combination treatment of Parkinsonism with L-dopa and a decarboxylase inhibitor (Benserazid, Ro 4-4602)]. Birkmayer W, Linauer W, Mentasti M, Riederer P. Wien Med Wochenschr; 1974 Jun 01; 124(22):340-4. PubMed ID: 4275492 [No Abstract] [Full Text] [Related]
6. Is the decreasing responsiveness of axial motor symptoms to L-dopa in elderly parkinsonian patients related to age-associated nonparkinsonian pathologies? Ransmayr G, Künig G, Neubauer M, Wagner M, Bösch S, Kreczy-Kleedorfer B. Adv Neurol; 1993 Jun 01; 60():685-9. PubMed ID: 8420211 [No Abstract] [Full Text] [Related]
7. A quantitative evaluation of the effects of L-dopa on Parkinson's disease. Velasco F, Velasco M. Neuropharmacology; 1973 Feb 01; 12(2):89-99. PubMed ID: 4595553 [No Abstract] [Full Text] [Related]
9. The role of a dihydromorphanthridine derivative in Parkinson's patients treated with L-dopa. A preliminary report. Wycis HT. Confin Neurol; 1972 Feb 01; 34(2):130-5. PubMed ID: 4666056 [No Abstract] [Full Text] [Related]
11. [Treatment of parkinsonism with the drug L-DOPA]. Stoliarova LG, Kistenev BA. Zh Nevropatol Psikhiatr Im S S Korsakova; 1973 Feb 01; 73(2):199-205. PubMed ID: 4795170 [No Abstract] [Full Text] [Related]
12. [L-dopa treatment of parkinsonism]. Szulc-Kuberska J, Niewodniczy A, Poźniak-Patewicz E, Wolczyk-Orzechowska M. Neurol Neurochir Pol; 1973 Feb 01; 7(1):63-8. PubMed ID: 4511385 [No Abstract] [Full Text] [Related]
13. [Quantitative rigor determination in Parkinson's disease. Myo-integration for therapy control of L-Dopa in combination with a decarboxylase inhibitor (Ro 8-0576)]. Gehlen W, Eisenlohr JJ. Nervenarzt; 1974 Jan 01; 45(2):22-9. PubMed ID: 4601993 [No Abstract] [Full Text] [Related]
14. Early detection of L-dopa response in parkinsonian patients with a standardized tracking test. Albani C, Buck A. Adv Neurol; 1993 Jan 01; 60():386-9. PubMed ID: 8420158 [No Abstract] [Full Text] [Related]
15. H-reflex in patients with parkinsonism: effect of levodopa. Herbison GJ. Arch Phys Med Rehabil; 1973 Jul 01; 54(7):291-5 passim. PubMed ID: 4718235 [No Abstract] [Full Text] [Related]
18. [Psychologic evaluation of amantadine treatment of parkinsonism and comparative analysis of the effects with L-dopa]. Puca FM, Micalizzi V, Megna GF, Barbieri NF, Pigneri MT. Acta Neurol (Napoli); 1971 Jul 01; 26(6):707-30. PubMed ID: 4946491 [No Abstract] [Full Text] [Related]
19. [The therapeutic effect of L-dopa]. Groneberg P, Struppler A. Naturwissenschaften; 1972 Nov 01; 59(11):492-6. PubMed ID: 4657650 [No Abstract] [Full Text] [Related]
20. [L-dopa treatment of persons with parkinsonism in a hospital for geriatric rehabilitation]. Antonini F, Baroni A, Roveyaz L. Sist Nerv; 1970 Nov 01; 22(2):74-81. PubMed ID: 5504560 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]